Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1992 Oct;68(4):369–373. doi: 10.1136/hrt.68.10.369

Early vasodilator treatment in myocardial infarction: appropriate for the majority or minority?

A D Hargreaves 1,2,3, T Kolettis 1,2,3, A J Jacob 1,2,3, L L Flint 1,2,3, L W Turnbull 1,2,3, A L Muir 1,2,3, N A Boon 1,2,3
PMCID: PMC1025134  PMID: 1449918

Abstract

Objective—To assess the influence of vasodilator treatment started early after myocardial infarction on left ventricular size and function.

Setting—Coronary care unit, Royal Infirmary, Edinburgh.

Patients—105 patients with acute myocardial infarction (systolic blood pressure >90 mm Hg) were randomised within 24 hours of the start of pain. Unlike previous studies 88% of the patients received thrombolysis.

Methods—Double blind randomised placebo controlled study with either 12·5 mg of captopril three times daily or 20 mg of isosorbide mononitrate three times daily for 28 days.

Main outcome measures—Clinical outcome and left ventricular size and function assessed by echocardiography, radionuclide ventriculography, and magnetic resonance imaging.

Results—There was no difference in left ventricular size or function in either treatment group as measured one week after the end of the trial. Even the placebo group tended to decrease left ventricular diameter over the four week study period (one week: 5·0 (0·1) ν, five weeks: 4·8 (0·1) cm, NS). Four patients had an adverse clinical outcome in the placebo group whereas no adverse outcome was seen in the captopril group.

Conclusions—Vasodilator treatment may be of limited value or of no benefit for most infarct patients, particularly those treated with thrombolytic agents. Captopril, however, may benefit patients at high risk.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dalen J. E., Gore J. M., Braunwald E., Borer J., Goldberg R. J., Passamani E. R., Forman S., Knatterud G. Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial. Am J Cardiol. 1988 Aug 1;62(4):179–185. doi: 10.1016/0002-9149(88)90208-1. [DOI] [PubMed] [Google Scholar]
  2. De Feyter P. J., van Eenige M. J., van der Wall E. E., Bezemer P. D., van Engelen C. L., Funke-Kupper A. J., Kerkkamp H. J., Visser F. C., Roos J. P. Effects of spontaneous and streptokinase-induced recanalization on left ventricular function after myocardial infarction. Circulation. 1983 May;67(5):1039–1044. doi: 10.1161/01.cir.67.5.1039. [DOI] [PubMed] [Google Scholar]
  3. Eaton L. W., Weiss J. L., Bulkley B. H., Garrison J. B., Weisfeldt M. L. Regional cardiac dilatation after acute myocardial infarction: recognition by two-dimensional echocardiography. N Engl J Med. 1979 Jan 11;300(2):57–62. doi: 10.1056/NEJM197901113000202. [DOI] [PubMed] [Google Scholar]
  4. Ertl G., Kloner R. A., Alexander R. W., Braunwald E. Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor. Circulation. 1982 Jan;65(1):40–48. doi: 10.1161/01.cir.65.1.40. [DOI] [PubMed] [Google Scholar]
  5. Hochman J. S., Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation. 1987 Jan;75(1):299–306. doi: 10.1161/01.cir.75.1.299. [DOI] [PubMed] [Google Scholar]
  6. Jeremy R. W., Allman K. C., Bautovitch G., Harris P. J. Patterns of left ventricular dilation during the six months after myocardial infarction. J Am Coll Cardiol. 1989 Feb;13(2):304–310. doi: 10.1016/0735-1097(89)90503-2. [DOI] [PubMed] [Google Scholar]
  7. Jeremy R. W., Hackworthy R. A., Bautovich G., Hutton B. F., Harris P. J. Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction. J Am Coll Cardiol. 1987 May;9(5):989–995. doi: 10.1016/s0735-1097(87)80298-x. [DOI] [PubMed] [Google Scholar]
  8. Jugdutt B. I., Warnica J. W. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location. Circulation. 1988 Oct;78(4):906–919. doi: 10.1161/01.cir.78.4.906. [DOI] [PubMed] [Google Scholar]
  9. Kennedy J. W., Ritchie J. L., Davis K. B., Stadius M. L., Maynard C., Fritz J. K. The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report. N Engl J Med. 1985 Apr 25;312(17):1073–1078. doi: 10.1056/NEJM198504253121701. [DOI] [PubMed] [Google Scholar]
  10. O'Rourke M., Baron D., Keogh A., Kelly R., Nelson G., Barnes C., Raftos J., Graham K., Hillman K., Newman H. Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator. Circulation. 1988 Jun;77(6):1311–1315. doi: 10.1161/01.cir.77.6.1311. [DOI] [PubMed] [Google Scholar]
  11. Oldroyd K. G., Pye M. P., Ray S. G., Christie J., Ford I., Cobbe S. M., Dargie H. J. Effects of early captopril administration on infarct expansion, left ventricular remodeling and exercise capacity after acute myocardial infarction. Am J Cardiol. 1991 Sep 15;68(8):713–718. doi: 10.1016/0002-9149(91)90641-w. [DOI] [PubMed] [Google Scholar]
  12. Pfeffer M. A., Lamas G. A., Vaughan D. E., Parisi A. F., Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 1988 Jul 14;319(2):80–86. doi: 10.1056/NEJM198807143190204. [DOI] [PubMed] [Google Scholar]
  13. Pirolo J. S., Hutchins G. M., Moore G. W. Infarct expansion: pathologic analysis of 204 patients with a single myocardial infarct. J Am Coll Cardiol. 1986 Feb;7(2):349–354. doi: 10.1016/s0735-1097(86)80504-6. [DOI] [PubMed] [Google Scholar]
  14. Sharpe N., Murphy J., Smith H., Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet. 1988 Feb 6;1(8580):255–259. doi: 10.1016/s0140-6736(88)90347-9. [DOI] [PubMed] [Google Scholar]
  15. Sharpe N., Smith H., Murphy J., Greaves S., Hart H., Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition. Lancet. 1991 Apr 13;337(8746):872–876. doi: 10.1016/0140-6736(91)90202-z. [DOI] [PubMed] [Google Scholar]
  16. Wathen C. G., Muir A. L., Hannan W. J. Radionuclide studies of left ventricular function in normal subjects. Nucl Med Commun. 1990 Sep;11(9):607–615. doi: 10.1097/00006231-199009000-00004. [DOI] [PubMed] [Google Scholar]
  17. White H. D., Norris R. M., Brown M. A., Takayama M., Maslowski A., Bass N. M., Ormiston J. A., Whitlock T. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N Engl J Med. 1987 Oct 1;317(14):850–855. doi: 10.1056/NEJM198710013171402. [DOI] [PubMed] [Google Scholar]
  18. Yusuf S., Collins R., MacMahon S., Peto R. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials. Lancet. 1988 May 14;1(8594):1088–1092. doi: 10.1016/s0140-6736(88)91906-x. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES